A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitis
NCT ID: NCT05571943
Last Updated: 2024-08-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
542 participants
INTERVENTIONAL
2022-09-15
2024-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
This Study is to Assess the Efficacy of Difamilast Ointment in Mild to Moderate Atopic Dermatitis(AD)
NCT05608343
A Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic Dermatitis
NCT04040192
Study Evaluating Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis
NCT03575871
Study of 0416 Ointment in the Treatment of Atopic Dermatitis
NCT01053247
A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.
NCT05375955
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Difamilast Ointment 1%
A thin layer of Difamilast applied to affected areas twice daily (morning and evening, approximately 12 hours apart)
Difamilast
Difamilast Ointment 1%
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Difamilast
Difamilast Ointment 1%
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Subjects who have a diagnosis of AD based on the American Academy of Dermatology AD diagnostic criteria
3. Subjects who have had a diagnosis of AD for at least 3 months prior to Screening .
4. Subjects who have an IGA of mild or moderate AD Severity and treatable body surface area (BSA) ≥3%at Baseline if not previously enrolled in study MEDI-MM36-301 OR b. IGA ≤ 3, with no minimum BSA and completed through Week 4/EOT Visit 6 of the study MEDI-MM36-301.
5. Subject is willing and able to comply with all study-related procedures, including, but not limited to, application of the study drug, and visit requirements.
Exclusion Criteria
2. Subjects who have an active or acute skin infection (eg, herpes simplex, herpes zoster, or chicken pox), and/or clinically infected AD
3. Subjects with significant systemic or localized infection
4. Subjects with minimal/mild depression and suicidal ideation
5. Subjects using restricted medications, biologics and alternative therapies, or using investigational drug
\-
2 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Acrotech Biopharma Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Uma S Atmuri, MPharm MS
Role: STUDY_DIRECTOR
Acrotech Biopharma Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Qualmedica Research, LLC
Birmingham, Alabama, United States
AllerVie Health
Birmingham, Alabama, United States
Elite Clinical Studies, LLC
Phoenix, Arizona, United States
NEA Baptist Clinic-Dermatology
Jonesboro, Arkansas, United States
First OC Dermatology
Fountain Valley, California, United States
Center for Dermatology Clinical Research, Inc.
Fremont, California, United States
Southern CA Dermatology Skin and Laser
Laguna Niguel, California, United States
Antelope Valley Clinical Trials
Lancaster, California, United States
Dermatology Research Associates
Los Angeles, California, United States
Clinical Trials Research Institute
Thousand Oaks, California, United States
Clarity Dermatology, LLC
Castle Rock, Colorado, United States
IMMUNOe Research Centers
Centennial, Colorado, United States
TrueBlue Clinical Research
Brandon, Florida, United States
Annexus Dermatology & Aethestics
DeLand, Florida, United States
Accel Research - Edgewater Clinical Research Unit
Edgewater, Florida, United States
Skin Care Research
Hollywood, Florida, United States
Kirsch Dermatology
Naples, Florida, United States
Tory Sullivan, MD PA
North Miami Beach, Florida, United States
Pure Skin Dermatology & Aesthetics
Orlando, Florida, United States
Nona Pediatrics
Orlando, Florida, United States
Accel Research - Ormond Clinical Research Unit
Ormond Beach, Florida, United States
Olympian Clinical Research
St. Petersburg, Florida, United States
Solaris Clinical Research
Meridian, Idaho, United States
Arlington Dermatology
Rolling Meadows, Illinois, United States
DS Research
Clarksville, Indiana, United States
Qualmedica Research, LLC
Evansville, Indiana, United States
Dawes Fretzin Clinical Research Group, LLC
Indianapolis, Indiana, United States
The Indiana Clinical Trials Center
Plainfield, Indiana, United States
South Bend Clinic
South Bend, Indiana, United States
Options Research Group, LLC
West Lafayette, Indiana, United States
Meridian Clinical Research
Overland Park, Kansas, United States
Qualmedica Research, LLC
Bowling Green, Kentucky, United States
DS Research
Louisville, Kentucky, United States
Clinical Trials Management, LLC
Covington, Louisiana, United States
Avant Research Associates, LLC
Crowley, Louisiana, United States
Clinical Trials Management, LLC
Metairie, Louisiana, United States
DermAssociates, LLC
Rockville, Maryland, United States
Metro Boston Clinical Partners
Brighton, Massachusetts, United States
Oakland Hills Dermatology, PC
Auburn Hills, Michigan, United States
Michigan Dermatology Institute
Waterford, Michigan, United States
Minnesota Clinical Study Center
New Brighton, Minnesota, United States
Cleaver Dermatology
Kirksville, Missouri, United States
Vivida Dermatology
Las Vegas, Nevada, United States
Forest Hills Dermatology Group
Kew Gardens, New York, United States
Bexley Dermatology Research
Bexley, Ohio, United States
Optima Research
Boardman, Ohio, United States
Remington-Davis, Inc.
Columbus, Ohio, United States
Optimed Research
Columbus, Ohio, United States
Oregon Health and Science University
Portland, Oregon, United States
Dermatology Associates of Plymouth Meeting
Plymouth Meeting, Pennsylvania, United States
Peak Research, LLC
Upper Saint Clair, Pennsylvania, United States
Palmetto Clinical Trial Services, LLC
Anderson, South Carolina, United States
Coastal Pediatric Research
Charleston, South Carolina, United States
International Clinical Research - Tennessee, LLC
Murfreesboro, Tennessee, United States
Arlington Research Center, Inc.
Arlington, Texas, United States
Derm Research
Austin, Texas, United States
J&S Studies
College Station, Texas, United States
North Texas Center for Clinical Research
Frisco, Texas, United States
Center for Clinical Studies, Ltd, LLP
Houston, Texas, United States
Research Your Health
Plano, Texas, United States
Houston Center for Clinical Research
Sugar Land, Texas, United States
Center for Clinical Studies
Webster, Texas, United States
Premier Clinical Research, LLC
Spokane, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MM36-302
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.